1. Skin toxicity with anti-EGFR monoclonal antibody in cancer patients: a meta-analysis of 65 randomized controlled trials

   • Jing Li
   • Hengxiu Yan

   Review Article 13 July 2018 Pages: 571 - 583

   

2. A phase I/II study of GLIF combination chemotherapy for taxane/platinum-refractory/resistant endometrial cancer (GOGO-EM2)

   • Yusuke Tanaka
   • Yutaka Ueda
   • Tadashi Kimura

   Original Article Open access 20 July 2018 Pages: 585 - 592

   

3. Repression of GRIM19 expression potentiates cisplatin chemoresistance in advanced bladder cancer cells via disrupting ubiquitination-mediated Bcl-xL degradation

   • Feng Ni
   • Chang-you Yan
   • Zhi-gang Zhang

   Original Article 21 July 2018 Pages: 593 - 605

   

4. Randomized controlled clinical trial of polyethylene glycol recombinant human granulocyte colony-stimulating factor in the treatment of neutropenia after chemotherapy for breast cancer

   • Weiwei Huang
   • Jian Liu
   • Lin Lin

   Original Article 24 July 2018 Pages: 607 - 613

   

5. Tolerance, variability, and pharmacokinetics of bevacizumab biosimilars in Chinese healthy male subjects

   • Hong Zhang
   • Qingmei Li
   • Yanhua Ding

   Original Article 24 July 2018 Pages: 615 - 623

   

6. The risk factors for oxaliplatin-induced peripheral sensory neuropathy and thrombocytopenia in advanced gastric cancer

   • Kyoko Yamaguchi
   • Hitoshi Kusaba
   • Eishi Baba

   Original Article 24 July 2018 Pages: 625 - 633

   

7. Identification and preclinical characterization of a novel and potent poly (ADP-ribose) polymerase (PARP) inhibitor ZYTP1

   • Mukul R. Jain
   • Jogeswar Mohapatra
   • Ranjit C. Desai

   Original Article 25 July 2018 Pages: 635 - 647

   

8. Expression of vascular endothelial growth factor receptor 2 and clinical response to lenvatinib in patients with anaplastic thyroid cancer

   • Haruhiko Yamazaki
   • Tomoyuki Yokose
   • Munetaka Masuda

   Original Article 26 July 2018 Pages: 649 - 654

   

9. Nab-paclitaxel plus S-1 as first-line followed by S-1 maintenance for advanced pancreatic adenocarcinoma: a single-arm phase II trial

   • Wen Zhang
   • Chunxia Du
   • Aiping Zhou

   Original Article Open access 23 July 2018 Pages: 655 - 660

   

10. Multi-center clinical evaluation of streptozocin-based chemotherapy for advanced pancreatic neuroendocrine tumors in Japan: focus on weekly regimens and monotherapy

    • Hitoshi Shibuya
    • Susumu Hijioka
    • Takuji Okusaka

    Original Article 27 July 2018 Pages: 661 - 668

    

11. Pharmacodynamic modelling of resistance to epidermal growth factor receptor inhibition in brain metastasis mouse models

    • Emma C. Martin
    • Leon Aarons
    • James W. T. Yates

    Original Article Open access 27 July 2018 Pages: 669 - 675

    

12. Lipid profiling of pre-treatment plasma reveals biomarker candidates associated with response rates and hand–foot skin reactions in sorafenib-treated patients

    • Kosuke Saito
    • Masafumi Ikeda
    • Shunsuke Kondo

    Original Article 30 July 2018 Pages: 677 - 684

    

13. An open-label feasibility study of nintedanib combined with docetaxel in Japanese patients with locally advanced or metastatic lung adenocarcinoma after failure of first-line chemotherapy

    • Noboru Yamamoto
    • Hirotsugu Kenmotsu
    • Kazuhiko Nakagawa

    Original Article Open access 03 August 2018 Pages: 685 - 694

    

14. A phase 1 dose-escalation study on the safety, tolerability and activity of liposomal curcumin (Lipocurc^™) in patients with locally advanced or metastatic cancer

    • Richard Greil
    • Sigrun Greil-Ressler
    • Peter P. Sordillo

    Original Article Open access 03 August 2018 Pages: 695 - 706

    

15. Phase II trial of capecitabine plus oxaliplatin (CAPOX) as perioperative therapy for locally advanced rectal cancer

    • Junichi Nishimura
    • Junichi Hasegawa
    • Clinical Study Group of Osaka University (CSGO) Colorectal Group

    Original Article 04 August 2018 Pages: 707 - 716

    

16. Comparison of levetiracetam with phenytoin for the prevention of intravenous busulfan-induced seizures in hematopoietic cell transplantation recipients

    • Kana Akiyama
    • Tetsuo Kume
    • Takashi Ikeda

    Original Article Open access 06 August 2018 Pages: 717 - 721

17. A phase I trial of topotecan plus tivantinib in patients with advanced solid tumors

    • Stephen V. Liu
    • Susan G. Groshen
    • Edward M. Newman

    Clinical Trial Report 20 August 2018 Pages: 723 - 732

    

18. Lapatinib with ECF/X in the first-line treatment of metastatic gastric cancer according to HER2neu and EGFR status: a randomized placebo-controlled phase II study (EORTC 40071)

    • Markus Moehler
    • Arno Schad
    • the EORTC Gastrointestinal Tract Cancer Group

    Short Communication 13 August 2018 Pages: 733 - 739